Active truncated form of the RNA polymerase of flavivirus

Details Active truncated form of the RNA polymerase of flavivirus Active truncated form of the RNA polymerase of flavivirus

2008-10-22

2011-10-04

Mosher, Mary E (Department: 1648)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Transferase other than ribonuclease

C435S005000

Reexamination Certificate

active

08030047

ABSTRACT:
The isolation and purification of two domains from a from aflavivirusis provided. Each domain can function independently. Moreover, one domain codes for a sequence that provide polymerase activity. A process for screening possible modulators of the polymerase activity of an isolated and purified polypeptide fromflavivirusis also disclosed.

REFERENCES:
patent: 6949353 (2005-09-01), Romette et al.
patent: 7459297 (2008-12-01), Romette et al.
patent: 2654113 (1991-05-01), None
patent: WO01/60847 (2001-08-01), None
Guyatt et al (Journal of Virological Methods 92:37-44, 2001).
Grun et al (Journal of Virology 61:3641-3644, 1987).
U.S. Appl. No. 12/255,967, filed Oct. 22, 2008, Romette, et al.
Marie-Pierre Egloff, et al., “An RNA Cap (Nucleoside-2′-O-)-Methyltransferase in theFlavivirusRNA Polymerase NS5: Crystal Structure and Functional Characterization”, EMBO J. 2002, 21: pp. 2757-2768.
Michael Mc Lai, “RNA Polymerase as an Antiviral Target of Hepatitis C Virus”, Antiviral Chemistry & Chemotherapy, 2001,12, Suppl. 1: pp. 143-147.
Michelle P. Walker, et al., “HCV RNA-Dependent RNA Polymerase as a Target for Antiviral Development”, Current Opinion in Pharmacology 2002, 2: pp. 1-7.
A. Mlinaric, et al., “Screening of Selected Plant Extracts for In Vitro Inhibitory Activity on HIV-1 Reverse Transcriptase (HIV-1 RT)”, Pharmazie 2000, 55: pp. 75-77.
Renate Mentel, et al., “Inhibition of Adenovirus DNA Polymerase by Modified Nucleoside Triphosphate Analogs Correlate with their Antiviral Effects on Cellular Level”, Med Microbiology Immunology, 2000,189: pp. 91-95.
Fabien Zoulim, “Therapy of Chronic Hepatitis B Virus Infection: Inhibition of the Viral Polymerase and other Antiviral Strategies”, Antiviral Res; 1999, 44: pp. 1-30.
Meitian Wang, et al., “Non-nucleoside Analogue Inhibitors Bind to an Allosteric Site on HCV NS5B Polymerase: Crystal Structures and Mechanism of Inhibition” The Journal of Biological Chemistry, 2003, 278: pp. 9489-9495.
Steven S. Carroll, et al., “Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs”, The Journal of Biological Chemistry, 2003, 278: pp. 11979-11984.
Scott G. Baginski, et al., “Mechanism of Action of aPestivirusAntiviral Compound”, Proc Natl Acad Sci USA, 2000, 97: pp. 7981-7986.
G. Campiani, et al., “Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors: Synthesis and Biological Evaluation of Novel Quinoxalinylethylpyridylthioureas as Potent Antiviral Agents”, Antiviral Chemistry & Chemotherapy, 2000,11: pp. 141-155.
Anastasya L. Khandazhinskaya, et al., “Carbocyclic Dinucleoside Polyphosphonates: Interaction with HIV Reverse Transcriptase and Antiviral Activity”, Journal of Medical Chemistry, 2002, 45: pp. 1284-1291.
Erik De Clercq, “Antiviral Drugs: Current State of the Art”, Journal of Clinical Virology, 2001: pp. 73-89.
Hélène Malet, et al., “Crystal Structure of the RNA Polymerase Domain of the West Nile Virus Non-Structural Protein 5”, Journal of Biological Chemistry, 282: pp. 10678-10689, (2007).
Thai Leong Yap, et al., “Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution”, Journal of Virology, 81: pp. 4753-4765, (2007).
Brooks et al., “The interdomain region of dengue NS5 protein that binds to the viral helicase NS3 contains independently functional importin beta 1 and importin alpha/beta-recognized nuclear localization signals,” The Journal of Biological Chemistry, vol. 277, No. 39 (2002), 36399-36407.
Johansson et al., “A small region of the dengue virus-encoded RNA-dependent RNA polymerase, NS5, confers interaction with both the nuclear transport receptor importin—and the viral helicase, NS3,” Journal of General Virology, 82: 735-745 (2001).
Yaegashi et al., “Partial sequence analysis of cloned dengue virus type 2 genome,” Gene, 46: 257-267 (1986).
Result 8, rpr, (2006).
Sequence search result 3 from .rag, (2006).
Sequence search results 1-5 from .rpr; search results 1-60 from .rup, (2006).
See SCORE sequence search result 14.rag (search done Jun. 1, 2006).
Bartholomeusz et al., “Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5,” Arch Virol, 128, pp. 111-121 (1993).
Tan et al (Virology 216:317-325, 1996).
Johansen et al (Journal of General Virology 82:735-745, 2001).
Vasudevan et al ( Farmaco 56:33-36, 2001).

Affiliated with

Also associated with

Rating

Active truncated form of the RNA polymerase of flavivirus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Active truncated form of the RNA polymerase of flavivirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Active truncated form of the RNA polymerase of flavivirus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4283119